ABSTRACT: Ergot alkaloids are hypothesized to cause vasoconstriction in the midgut, and prior exposure may affect the vasoactivity of these compounds. The objectives of this study were to profile vasoactivity of ergot alkaloids in bovine mesenteric artery (MA) and vein (MV) and determine if previous exposure to endophyte-infected tall fescue seed affected vasoactivity of ergocryptine (ERP), ergotamine (ERT), ergocristine (ERS), ergocornine (ERO), ergonovine (ERN), lysergic acid (LSA), ergovaline-containing tall fescue seed extract (EXT), and 5-hydroxytryptamine (5HT; serotonin). Ruminally cannulated Angus steers (n = 12; BW = 547 ± 31 kg) were paired by weight and randomly assigned to 6 blocks. Steers were ruminally dosed daily with 1 kg of either endophyte-infected (E+; 4.45 mg ergovaline/ kg DM) or endophyte-free (E-; 0 mg ergovaline/kg DM) tall fescue seed for 21 d before slaughter. Branches of MA and MV supporting the cranial portion of the ileum were collected after slaughter on d 22, placed in a modified Krebs-Henseleit buffer on ice, cleaned, sectioned, and mounted in a multimyograph chamber. Contractile response was normalized to a maximum KCl response.
INTRODUCTION
Neotyphodium coenphialum is an endophyte symbiotically associated with tall fescue grass (Lolium arundinaceum; Porter et al., 1979; Bush et al., 1982) . The endophyte, although conveying beneficial properties to the grass, such as insect and drought resistance, produces a number of ergot alkaloids that cause vasoconstriction and fescue toxicosis in grazing animals Strickland et al., 2011) . Ergot alkaloids induce vasoconstriction in bovine core (Rhodes et al., 1991) , peripheral (Solomons et al., 1989; Klotz et al., 2006; Aiken et al., 2007) , and foregut (Foote et al., 2011 ) blood vessels and have been shown to decrease blood flow to the rumen epithelium (Foote et al., 2013) . Westendorf et al. (1993) reported that 50% to 60% of ergot alkaloids administered in the diet were recovered in the abomasum; thus, it follows that ergot alkaloids enter the small intestine. However, little information is available about the effect of these compounds on the small intestine or what interaction alkaloids might have with the midgut. Klotz et al. (2012) demonstrated a reduction in contractile response to 5-hydroxytryptamine (5HT; serotonin) and ergovaline in lateral saphenous veins collected from steers that had grazed high-endophyte tall fescue. Therefore, it was hypothesized that ergot alkaloids cause vasoconstriction in midgut vasculature and that prior dietary exposure to ergot alkaloids may decrease their vasoactivity. The objectives of this study were to profile the vasoactivity of ergot alkaloids in the mesenteric artery (MA) and vein (MV) and to determine if prior dietary exposure to toxic endophyte-infected tall fescue seed affected in vitro vasoactivity of ergocryptine (ERP), ergotamine (ERT), ergocristine (ERS), ergocornine (ERO), ergonovine (ERN), lysergic acid (LSA), an ergovalinecontaining tall fescue seed extract (EXT), and 5HT.
MATERIALS AND METHODS
The procedures used in this study involving live animals were approved by the University of Kentucky Institutional Animal Care and Use Committee.
Animals and Seed Treatment
Twelve ruminally cannulated Angus steers (BW = 547 ± 31 kg) were paired by weight into 6 blocks and housed at the University of Kentucky C. Oran Little Research Center in Woodford County. Steers were fed a basal diet of alfalfa cubes (% DM basis: CP = 16.5; ADF = 37.2; NDF = 51.9; NE m = 5.19 MJ/kg) at 1.5 × NE m once daily at 0700 h; the diet was topdressed with a mineral premix (Kentucky Nutrition Service, Lawrenceburg, KY; NaCl = 92%; Zn = 5,500 mg/kg; Fe = 9,275 mg/kg; Mn = 4,790 mg/kg; Cu = 1,835 mg/kg; I = 115 mg/kg; Se = 18 mg/kg; Co = 65 mg/kg). Steers were given free access to water. Within each block, 1 steer was randomly assigned to an endophyte-infected (E+; "KY 31") tall fescue seed treatment, and the other was assigned to an endophyte-free (E-; "KY 32") tall fescue seed treatment. Tall fescue seed was ground by a grinder mixer (MX125, Gehl, West Bend, WI) to pass through a 1.25-cm screen. Steers were dosed through the rumen cannula immediately after feeding with 1 kg of E-(0 mg ergovaline + ergovalinine/kg DM) or E+ (4.45 mg ergovaline + ergovalinine/kg DM) seed daily for 21 d before slaughter.
The starting points of feeding periods were staggered to accommodate slaughter of 1 block per week with 1 d in between slaughters within a week to allow for completion of myograph experiments.
Blood Collection and Analysis
Blood samples were collected from steers immediately before feeding on d 14 via a catheter in the jugular vein. The blood was permitted to clot for 24 h at 4°C and centrifuged (1,500 × g) for 25 min at 4°C. Analysis of serum prolactin concentrations was conducted by the RIA procedures of Bernard et al. (1993) . Intra-and interassay CV were 6.6% and 7.1%, respectively.
Tissue Collection and Preparation
On d 22, steers were slaughtered at the University of Kentucky Meat Laboratory (E+: BW = 564 ± 16 kg; E-: BW = 585 ± 8 kg). Shortly after the gastrointestinal tract was removed from the carcass, branches of MA and MV supporting the cranial portion of the ileum were collected, placed in a modified Krebs-Henseleit buffer (95% O 2 /5% CO 2 ; pH = 7.4; 11.1 mM D-glucose; 1.2 mM MgSO4; 1.2 mM KH 2 PO 4 ; 4.7 mM KCl; 118.1 mM NaCl; 3.4 mM CaCl 2 ; 24.9 mM NaHCO 3 ; Sigma Chemical Co., St. Louis, MO) on ice, and transported to the laboratory. Mesenteric artery and MV were separated and carefully cleaned of fat and connective tissue. Samples were sectioned into approximately 2-mm segments and examined under 12.5× magnification using a dissecting microscope (Stemi 2000-C, Carl Zeiss Inc., Oberkochen, Germany). At that time, segments of vessel that were found to have abnormalities or to be structurally compromised were replaced with an uncompromised segment. Because of the noncircular nature of MV, vascular measurements were recorded for MA cross sections only using Axiovision (version 20, Carl Zeiss Inc.).
Standards and Concentrations
Stock solutions of ERP, ERT, ERS, ERO, ERN, EXT, LSA, and 5HT were diluted to corresponding concentrations for final working concentrations in the tissue bath of 5 × 10 -10 to 1 × 10 -6 M for EXT and 5 × 10 -9 to 1 × 10 -4 M for all other agonists. Alpha-ergocryptine (99%; E5625; Sigma Chemical Co.), ERT (ergotamine d-tartrate; 97%; 45510; Aldrich, Milwaukee, WI), ERS (erogcristine; Research Plus, Barnegat, NJ), ERO (ergocornine; 95%; E131; Sigma Chemical Co.), and ERN (ergonovine maleate salt; 100%; E6500; Sigma Chemical Co.) were prepared in dimethylsulfoxide. The EXT and LSA (d-lysergic acid; 95%; Acros Organics, Geel, Belgium) were prepared in 80% methanol, and 5HT (serotonin hydrochloride; 100%; H9523; Sigma Chemical Co.) was prepared in H 2 O. Because of limited availability of purified ergovaline, an ergovalinecontaining tall fescue seed extract was used. Foote et al. (2012) described the ultraperformance liquid chromatography/tandem mass spectrometry (Acquity UPLC-TQD; Waters Inc., Milford, MA) quantitative analysis of the alkaloid concentrations of this extract (the same extract lot was used in the current study) and also reported that the contractile response of the bovine lateral saphenous vein to an E+ seed extract and ergovaline alone were not different. Because the starting concentration of ergovaline in EXT was fixed (the maximum starting concentration was 1 × 10 -6 M), only 8 standard additions were used for EXT. For all other agonists, there were a total of 10 standard additions. All additions were added to myograph chambers in order of increasing concentration.
Experimental Myograph Protocol
Vessels were mounted onto luminal supports in individual chambers of a multimyograph (DMT 610M, Danish Myo Technology, Atlanta, GA) with 5 mL Krebs-Henseleit buffer and constant gassing (95% O 2 /5% CO 2 ; pH = 7.4; 37°C). The incubation buffer included the transport buffer composition as well as 3 × 10 -5 M desipramine (D3900; Sigma Chemical Co.) to inactivate reuptake of catecholamines by neurons and 1 × 10 -6 M propranolol (P0844; Sigma Chemical Co.) to block β-adrenergic receptors. An equilibration period of 90 min under the above conditions with buffer changes every 15 min was given to allow the vessels to equilibrate at a resting tension of approximately 1 g. Experimental tissues were exposed to a reference addition of 120 mM KCl (Sigma Chemical Co.) for 15 min to confirm tissue viability and responsiveness. Tissues were washed with incubation buffer every 15 min until the vessels returned to approximately 1 g tension. Once the return to resting tension had been reached, the standard additions were started for cumulative contractile response experiments. Treatments were added in 15-min cycles that consisted of a 9-min treatment incubation period, followed by two 2.5-min buffer washes, a final buffer replacement, and a 1-min recovery before the next standard addition. At the completion of the experiment, the vessels were once again exposed to 120 mM KCl to verify that vessels were viable for the duration of the experiment.
Data Collection and Analysis
Isometric contractile response of mesenteric vessels to KCl, ERP, ERT, ERS, ERO, EXT, ERN, LSA, and 5HT were digitized and recorded in grams of tension using Powerlab/8sp and Chart software (version 7.3, ADInstruments, Colorado Springs, CO). For each standard addition, the maximum tension (g) during the 9-min incubation period was recorded as the contractile response, which was then corrected for baseline tension as established immediately before the 120 mM KCl reference addition. Because of variations between animals and in tissue size, the contractile response was normalized as a percentage of the maximum grams of tension induced by the KCl reference addition to compensate for differences in tissue responsiveness. Response data are presented as the percentage mean contractile response ± SEM of the maximum contractile response produced by the 120 mM KCl reference addition. Sigmoidal concentration response curves of MA and MV to each ergot alkaloid were calculated and plotted using nonlinear regression with variable slope (GraphPad Prism 5, GraphPad Software Inc., La Jolla, CA). This tabulation involved a 3-parameter equation:
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where top and bottom are the percentage of 120 mM KCl maximum contractile response at the plateaus and EC 50 is the molar concentration of the agonist producing 50% of the KCl maximum response. Thus, EC 50 is a measure of the potency of a compound. For ease of understanding and to correspond with the response curve graphs, results were presented as the negative log of the EC 50 value.
Statistical Analysis
All statistical analyses were done using the MIXED model of SAS (SAS 9.3, SAS Inst. Inc., Cary, NC). Serum prolactin concentrations for E+ and E-treated steers were compared using a randomized block design. The maximum contractile response of MA and MV to 120 mM KCl, as well as the inner and outer diameters of MA (analyzed separately), were analyzed using a randomized block with replication design for the effect of seed. Contractile response to agonist treatments for MA and MV was analyzed separately as a randomized block with a split-plot treatment design. The whole-plot experimental unit was steer with seed as the treatment factor. Vessel was the subplot experimental unit, and alkaloid concentration was the subplot treatment factor. Model terms included the fixed effects of seed treatment, agonist concentration, and the interaction of seed × concentration. Analysis of the negative log EC 50 for each agonist was conducted using a randomized block with a split-plot treatment arrangement, and terms of the model included seed, agonist, and the interaction.
For all analyses, pairwise comparisons of least squares means (± SEM) were conducted if the probability of a greater F statistic in the ANOVA was significant for the tested effect. The LSD feature of SAS was performed for mean separation. Results denoted as being significant have probabilities P < 0.05, unless otherwise reported.
RESULTS
Steers treated with E+ seed had a lower (P = 0.05) mean serum prolactin concentration than the E-steers (E+: 0.48 ± 14.36 ng/mL; E-: 50.16 ± 14.36 ng/mL). The mean i.d. of MA was less (P = 0.04) for E+ steers than for E-steers (E+ = 0.62 ± 0.04 mm; E-= 0.74 ± 0.04 mm). Similarly, the mean o.d. of MA was smaller (P = 0.02) for E+ steers than E-steers (E+: 1.54 ± 0.04 mm; E-: 1.69 ± 0.04 mm). The maximum contractile response to 120 mM KCl was not different between seed treatments for MA (P = 0.33; E-: 2.67 ± 0.43 g; E+: 3.33 ± 0.43 g) or MV (P = 0.26; E-: 2.01 ± 0.18 g; E+: 1.81 ± 0.18 g).
All P-values reported for agonist treatment contractile responses are for the seed × concentration interaction, unless otherwise specified. All agonists were vasoactive in MA and MV of E-steers with the exception of LSA. In contrast, vessels of E+ steers did not respond to several agonists. Specifically, contractile responses to ERP were less (P < 0.01) in MA ( Fig. 1A) and MV (Fig. 1B ) from E+ steers than E-steers. Similarly, E+ steers had a significantly reduced contractile response to ERT in MA (P < 0.01; Fig.  2A ) and MV (P = 0.03; Fig. 2B ). The response to ERS was also decreased for E+ steers compared to E-steers in MA (P < 0.01; Fig. 3A ) and MV (P = 0.05; Fig. 3B ). The E+ steers had a reduced contractile response to ERO in MA (P < 0.01; Fig. 4A ), but this was not seen in MV (P = 0.998; Fig. 4B ).
The MA and MV of E+ steers had decreased (P < 0.01) contractile responses to ERN ( Fig. 5A and 5B). There was a tendency for E-to have a greater contractile response in MA when exposed to LSA (P = 0.105; Fig. 6A ). In MV, LSA produced a significant concentration effect (P < 0.01), but this was due to a reduction in tension over the period of the experiment and not a contractile response (Fig. 6B) .
The EXT, based on concentration of ergovaline, induced a larger isometric contraction in MA (P < 0.01; Fig. 7A ) and MV (P = 0.04; Fig. 7B ) of E-steers than E+ steers. Likewise, the contractile response in MA and MV of E+ steers was less (P < 0.01) than that of E-steers when exposed to 5HT (Fig. 8A and 8B) . 5-Hydroxytryptamine (1 × 10 -4 M addition) produced a very large contractile response, with MA of E-steers reaching approximately 70% and MV of E-steers reaching approximately 90% of the maximum contractile response induced by KCl.
For EC 50 analysis, an effect of agonist was present in MA (P < 0.01), without a seed (P = 0.95) or seed × agonist effect (P = 0.90; Table 1 ). The EC 50 value for ERN was not different from that of ERS or ERO in MA. Similarly, MV also showed an agonist effect (P < 0.01). Seed treatment did not affect potency in MV (P = 0.80), and there was a tendency (P = 0.10) for an interaction. The response of MA to 5HT was different from all other agonist treatments evidenced by a lower -log EC 50 value. This indicates 5HT reached 50% of the maximum contractile response at a greater concentration than other agonists, and thus, arteries were less sensitive to 5HT than the other agonists tested. However, MV did not show a 
, where top and bottom are the percentage of 120 mM KCl maximum contractile response at the plateaus and EC 50 is the molar concentration of alkaloid producing 50% of the KCl maximum response. similar pattern as EC 50 for 5HT was only different from ERO and EXT. As expected from previous myograph experiments with bovine vasculature, the artery and vein varied in sensitivity to the agonist treatments.
The EXT was the most potent agonist in MV of E-and E+ steers, with -log EC 50 values of 7.26 ± 0.42 and 7.09 ± 0.42 M, respectively (Table 1) . Negative log EC 50 values of ergopeptines, ERP, ERT, ERS, and ERO were not significantly different from one another in MV. However, another ergopeptine, the ergovaline in EXT, had a greater (P < 0.05) -log EC 50 compared to the 4 pure ergopeptines previously mentioned, signifying MV of steers were more sensitive to EXT than the other ergopeptine agonists tested (Table 1 ). 
DISCUSSION
This experiment was the first to demonstrate that ergot alkaloids are vasoactive in mesenteric vasculature in vitro using a bovine model. To distinguish differences between E+ and E-steers, it was important that the experimental model showed the E+ seed treatment provided an adequate quantity of ergot alkaloids to induce fescue toxicosis. Research has shown that most animals consuming endophyte-infected tall fescue or ergot alkaloids have decreased serum prolactin concentrations (Hurley et al., 1980) . Normally, dopamine inhibits prolactin secretion by interacting with D2 dopamine receptors (Lamberts and Macleod, 1990) . However, structural similarities of the ergoline ring structure of ergot alkaloids compared to dopamine allow ergot alkaloids to bind and act on D2 dopamine receptors (Berde and Stürmer 1978; Goldstein et al., 1980; Sibley and Creese, 1983) in the anterior pituitary gland and to inhibit secretion of prolactin (Schillo et al., 1988; Porter and Thompson, 1992) . Thus, decreased serum prolactin has frequently been used as a broad indicator of fescue toxicosis in cattle, but the degree of decrease does not indicate the level of ergot alkaloid exposure. The reduced blood prolactin concentrations (on d 14) of E+ steers in this study suggest that E+ seed dosed steers were experiencing effects of fescue toxicosis at the time of vessel harvest. Additionally, evidence of vasoconstriction of mesenteric vasculature due to E+ seed treatment was Figure 6 . Mean contractile response of mesenteric (A) artery and (B) vein to increasing concentrations of lysergic acid (LSA) for endophyte-infected (E+) and endophyte-free (E-) tall fescue seed-treated steers. (A) For artery, the effect of seed and concentration were significant (P < 0.05), and the interaction showed a tendency (P = 0.105), which was likely due to our experimental protocol and is not biologically significant. (B) For vein, the effect of concentration was significant (P < 0.01); however, seed demonstrated a tendency (P = 0.07), and seed × concentration was not significant (P = 0.13). Regression lines shown are due to using nonlinear regression analysis to fit the data to a sigmoidal concentration response curve that utilized the following equation Klotz et al. (2012) showed a decrease in i.d. of bovine lateral saphenous vein when steers grazed a high-endophyte tall fescue pasture compared to a low-endophyte mixed-grass pasture; however, no effect of endophyte level on o.d was present. Several researchers also found that ergot alkaloid exposure produced morphological changes in vasculature of livestock and thickening of small peripheral blood vessels (Julien et al., 1974; Williams et al., 1975; Garner and Cornell, 1978) . On the basis of the results presented here and reported in the literature, the seed treatment was effective at inducing fescue toxicosis. The decreased size of mesenteric arteries in ergot alkaloid-exposed cattle in this study could have possibly led to a decline in blood flow. In support of this hypothesis, Rhodes et al. (1991) showed that steers had reduced blood flow to the duodenum and other tissues (cerebellum, skin over the ribs, and colon) after consuming a high-endophyte diet. Likewise, sheep on a 30-d treatment of high-endophyte diet also displayed reduced blood flow to the adrenal glands and skin of the inner hind leg (Rhodes et al., 1991) . The gastrointestinal tract relies on splanchnic blood flow for its functions (Matheson et al., 2000) . As digesta move across the mucosal surface, arterial blood flow to that area increases to aid in nutrient absorption (Chou, 1992) . Thus, it is conceivable that the vasoconstriction evident in the E+ steers could have impaired nutrient uptake and transport by decreasing blood flow to and from mesenteric tissues.
Ergopeptines, including ERP, ERT, ERS, and ERO, if they induced a contractile response in mesenteric vasculature, appeared to begin demonstrating a response around 1 × 10 -6 M, and the maximum contractile intensity was around 20% to 40% of the KCl maximum. Ergonovine, an ergoline alkaloid, appeared to have an onset of contraction at a greater concentration (5 × 10 -6 M) than that of the ergopeptines yet also reached between 20% and 40% of the KCl maximum response. Therefore, ERN generally had lower -log EC 50 values than ergopeptine alkaloids (with the exception of ERS) in MV of E-steers, signifying it reached 50% of its maximum contractile response at a greater concentration and is therefore less potent. In contrast, research done using lateral saphenous veins from fescue-naïve cattle showed ERN induced the greatest maximal contractile response of the agonists tested, and the EC 50 value for ERN was not different from ERP or ERS (Klotz et al., 2010) . Likewise, ERN displayed similar EC 50 values to ERP, ERO, and ERS in bovine ruminal artery (Foote et al., 2011) . Also, MA of steers displayed similarities in contractile response and potency between ERN and ergopeptine alkaloids, particularly ERS and ERO. Therefore, it appears ERN behaves similarly to ergopeptine alkaloids. Differences in results between ERN and ergopeptine alkaloids could possibly be attributed to ERN lacking the peptide moiety of ergopeptine alkaloids, which can affect binding mode and affinity (Choudhary et al., 1995) . An example of this difference between ergoline and ergopeptine alkaloids can be demonstrated by bovine vesicular glutamate transporters (VGLUT) activity, which collects l-glutamate into synaptic vesicles for stimulation of glutamatergic neurons. The VGLUT activity was decreased 80% to 90% by ergovaline, ERO, ERT, and bromocriptine (synthetic ergopeptine alkaloid; Xue et al., 2011) . Conversely, a separate study showed alkaloids without the peptide moiety were poor inhibitors of VGLUT activity (Carlson et al., 1989) .
Although ERN and LSA are structurally similar ergoline alkaloids, ERN produced a contractile response, and LSA failed to induce vasoconstriction. This lack of vasoactive response after exposure of mesenteric vasculature to LSA agrees with other studies that showed LSA did not induce significant vasoconstriction in bovine right ruminal artery and vein (Foote et al., 2011) , and LSA produced only a slight contractile response in bovine lateral saphenous vein at supraphysiological concentrations (Klotz et al., 2006) . On the basis of this compilation of evidence, the hypothesis that LSA has no direct vasoconstrictive effect on bovine vasculature was supported.
Ergovaline is among the most researched ergot alkaloids in relation to fescue toxicosis and vasoconstriction, as it is one of the most toxic alkaloids and makes up approximately 57% to 73% of the total ergopeptines in endophyte-infected tall fescue (Yates et al., 1985; . Based on the results of Foote et al. (2012) , the contractile response of mesenteric vasculature generated with EXT could be attributed to ergovaline alone, not the combination of alkaloids. In this experiment, EXT reached approximately the same maximum contractile response as the other ergopeptines. However, this maximum was achieved at a much lower concentration than the other ergopeptines required to reached their maximum (1 × 10 -6 vs. 1 × 10 -4 M, respectively), demonstrating that the ergovaline in EXT is a more potent vasoconstrictor in bovine mesenteric vasculature than the other ergopeptines tested. Further evidence for this increased potency of ergovaline was provided by EXT having the greatest -log EC 50 values for all seed treatment and vessel types for which data were available. Ergovaline was previously found to be 75 times more potent than 5HT at inducing vasoconstriction of the uterine artery from pregnant cows (Dyer, 1993) . Previous myograph studies have similarly shown evidence of ergovaline as a very potent vasoconstrictor of bovine vasculature (Klotz et al., 2007 (Klotz et al., , 2008 Foote et al., 2011 Foote et al., , 2012 .
A consistent observation across both MA and MV in the current study was a reduced or abolished contractile response in the vessels from E+ treated steers. This is the first report of this observation in mesenteric vasculature, but in 2 separate grazing trials, Klotz et al. (2012 Klotz et al. ( , 2013 reported similar observations for reduced contractile responses of lateral saphenous veins to ergovaline and 5HT in E+ steers compared to E-steers. This reduced contractile response could be a result of changes in involved receptor populations and activity, physical limitations due to vasoconstriction, or changes in gene expression related to secondary messaging systems associated with G proteincoupled receptors (GPCR). Dyer (1993) proposed that activation of 5HT receptors could be the main cause for the toxic effects of endophyte-infected fescue after finding ketanserin, a 5HT 2A antagonist, reduced the contractile response of bovine uterine and fetal umbilical arteries to ergovaline, whereas specific α-adrenergic antagonists did not. Likewise, Schöning et al. (2001) showed ERT and ergovaline interact with 5HT 2A , 5HT 1B/1D , and α 1 -adrenergic receptors to cause vasoconstriction of a rat tail artery. Our study provides strong evidence that prior alkaloid exposure has an effect on 5HT vasoactivity because endophyte-infected seed dosed steers had a considerably decreased contractile response to 5HT in mesenteric vasculature compared to endophyte-free dosed steers. Klotz a-c Within a column for vein, means without a common superscript differ (P < 0.05).
1 −Log EC 50 = measure of potency of an agonist, expressed as the molar concentration of that agonist required to produce 50% of the maximum contractile response produced by the reference compound, in this case 120 mM KCl.
2 Lysergic acid failed to induce vasoconstrictive response, so it was not included in the data set for analysis of−log EC 50 values.
3 Some data were unable to be fit to a sigmoidal curve response, preventing the calculation of-log EC 50 values because of no response (NR). Therefore, variable numbers of experimental replicates resulted, which are denoted in parenthetical values after the SEM for -log EC 50 values. 4 Seed treatment: Angus steers (n = 12) were paired by weight into 6 blocks. Within each block, 1 steer was dosed ruminally with 1 kg endophyte-free (E-) tall fescue seed, and the other was dosed with the same quantity of endophyteinfected (E+) tall fescue seed. 5 Because of the ambiguity of results from sigmoidal regression, EC 50 values were not determined (ND) for extract treatment of endophyte-free (E-) seed treated steers.
6 5HT = 5-Hydroxytryptamine.
et al. (2012) demonstrated a similar occurrence in peripheral vasculature; bovine lateral saphenous veins of steers grazed on a high-endophyte tall fescue pasture exhibited reduced contractile responses to 5HT and ergovaline compared to those on low-endophyte pasture. Based on an evaluation of different serotonin receptor subtype agonists, Klotz et al. (2012) indicated that the 5HT 2A and 5HT 7 subtypes are involved in vasoconstriction of fescue toxicosis and are affected by chronic ergot alkaloid exposure via grazing. Because the mesenteric arteries of endophyte-infected dosed steers were smaller than endophyte-free dosed steers and thus vasoconstriction was already evident before myograph treatments, 1 hypothesis for the observed reduction in contractile response of E+ steers to agonist treatments was that the blood vessels of E+ steers were physically unable to contract as much as the E-treated vessels. However, comparison of the KCl maximum data for mesenteric artery and vein provides evidence that this was not true, as there was no effect of seed treatments on the maximum contractile responses to KCl for mesenteric artery or vein. Although still not fully understood, many studies have focused on determining the mechanism by which ergot alkaloids induce vasoconstriction of blood vessels. It is known that ergot alkaloids interact with biogenic amine receptors (Weber, 1980; Pertz and Eich, 1999) , such as dopaminergic (Larson et al., 1995) , serotonergic (Dyer, 1993) , α 1 -adrenergic (Schöning et al., 2001) , and α 2 -adrenergic (Oliver et al., 1998) receptors, to induce vascular effects and alter cellular activity. Receptors such as these are G protein-coupled transmembrane proteins with 7 helical domains (Goddard and Abrol, 2007) , which elicit secondary messenger responses on ligand binding. A report demonstrated that ergot alkaloids (ergovaline, ERP, ERT, and ERN), binding to D 2 dopamine receptors, inhibited the vasoactive intestinal peptide-stimulated production of cyclic adenosine monophosphate (AMP) in GH 4 ZR 7 cells (Larson et al., 1995) , which would reduce the intracellular concentration of cyclic AMP, thereby affecting signal transduction pathways and, ultimately, cellular function. Furthermore, numerous studies have shown that alkaloids can bind receptors in what appears to be an irreversible association with very slow dissociation from receptor sites (Silberstein, 1997; Schöning et al., 2001; Klotz et al., 2007) . Ergovaline bioaccumulation within bovine peripheral vasculature after repetitive exposure has been demonstrated in vitro, but the same phenomenon did not occur with LSA (Klotz et al., 2009) . Additionally, Mulac and Humpf (2011) found that accumulation of ergopeptine alkaloids occurred in relation to necrotic and apoptotic effects in human primary cells. Based on this information, it is possible that ergot alkaloids from the dietary exposure in our study may have remained bound to the receptors, eventually leading to a reduction in receptors on the cell surface due to an imbalance between receptor internalization and trafficking of new receptors to the cell surface (Tan et al., 2004) . As a result, this could have reduced the number of available receptors in the vessel tissue for further alkaloid binding and subsequent vasoconstriction, thereby decreasing the observed contractile response to myograph treatments. Another plausible explanation for this occurrence may be a downregulation of gene transcription for GPCR elicited by ergot alkaloids at the mRNA level (Maurer, 1981) . Additionally, ergot alkaloids appear to have a variety of mechanisms of action on receptors and second messengers with both agonistic and antagonistic effects in target tissues (Pertz and Eich, 1999; Schöning et al., 2001) , which have made finding 1 solution to the fescue toxicosis problem difficult.
Conclusions
This study demonstrated that ergot alkaloids, with the exception of lysergic acid, were vasoactive in the bovine midgut mesentery in vitro. Steers exposed to endophyteinfected tall fescue seed had diminished or lacked contractility to many ergot alkaloids and 5HT in the small intestinal vasculature. This suggests that dietary exposure to ergot alkaloids could affect absorption of nutrients within the animal by decreased blood flow to and from the midgut due to vasoconstriction. However, because steers that had already been dosed with endophyte-infected tall fescue seed exhibited a reduced contractile response in vitro compared to endophyte-free dosed steers, the vasoactive response to ergot alkaloids and biogenic amines is suppressed in chronically exposed cattle. Prevention of midgut absorption of ergot alkaloids is viewed as a viable solution to the fescue toxicosis syndrome. Along with determining the mechanism of ergot alkaloid absorption from the midgut, further research should be directed toward investigating the passage of nutrients through mesenteric vasculature of animals exposed to endophyteinfected and endophyte-free tall fescue seed.
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